- Home
- ALTO vs RLMD Comparison
ALTO vs RLMD Comparison
Compare ALTO & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- RLMD
- Stock Information
- Founded
- ALTO 2003
- RLMD 2004
- Country
- ALTO United States
- RLMD United States
- Employees
- ALTO N/A
- RLMD N/A
- Industry
- ALTO Major Chemicals
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- ALTO Industrials
- RLMD Health Care
- Exchange
- ALTO Nasdaq
- RLMD Nasdaq
- Market Cap
- ALTO 129.5M
- RLMD 110.6M
- IPO Year
- ALTO N/A
- RLMD N/A
- Fundamental
- Price
- ALTO $1.37
- RLMD $3.01
- Analyst Decision
- ALTO Strong Buy
- RLMD Hold
- Analyst Count
- ALTO 3
- RLMD 2
- Target Price
- ALTO $5.00
- RLMD $7.50
- AVG Volume (30 Days)
- ALTO 1.3M
- RLMD 117.3K
- Earning Date
- ALTO 11-06-2024
- RLMD 11-07-2024
- Dividend Yield
- ALTO N/A
- RLMD N/A
- EPS Growth
- ALTO N/A
- RLMD N/A
- EPS
- ALTO N/A
- RLMD N/A
- Revenue
- ALTO $1,002,536,000.00
- RLMD N/A
- Revenue This Year
- ALTO N/A
- RLMD N/A
- Revenue Next Year
- ALTO $7.36
- RLMD N/A
- P/E Ratio
- ALTO N/A
- RLMD N/A
- Revenue Growth
- ALTO N/A
- RLMD N/A
- 52 Week Low
- ALTO $1.18
- RLMD $1.88
- 52 Week High
- ALTO $3.00
- RLMD $7.22
- Technical
- Relative Strength Index (RSI)
- ALTO 38.70
- RLMD 31.18
- Support Level
- ALTO $1.31
- RLMD $3.06
- Resistance Level
- ALTO $1.39
- RLMD $3.43
- Average True Range (ATR)
- ALTO 0.12
- RLMD 0.20
- MACD
- ALTO -0.05
- RLMD -0.05
- Stochastic Oscillator
- ALTO 21.84
- RLMD 6.61
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.